Search Page

1

Cite

Share

Toward a Lifestyle Medicine Approach to Illness Anxiety Disorder (Formerly Hypochondriasis).

Chappell AS. Chappell AS. Am J Lifestyle Med. 2018 Apr 27;12(5):365-369. doi: 10.1177/1559827618764649. eCollection 2018 Sep-Oct. Am J Lifestyle Med. 2018. PMID: 30283260 Free PMC article. Review.

Cite

Share

2

Cite

Share

Tailoring chronic pain treatments for the elderly: are we prepared for the challenge?

Arneric SP, Laird JM, Chappell AS, Kennedy JD. Arneric SP, et al. Among authors: chappell as. Drug Discov Today. 2014 Jan;19(1):8-17. doi: 10.1016/j.drudis.2013.08.017. Epub 2013 Aug 31. Drug Discov Today. 2014. PMID: 24001595 Review.

Cite

Share

3

Cite

Share

Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.

Edwards RR, Dworkin RH, Turk DC, Angst MS, Dionne R, Freeman R, Hansson P, Haroutounian S, Arendt-Nielsen L, Attal N, Baron R, Brell J, Bujanover S, Burke LB, Carr D, Chappell AS, Cowan P, Etropolski M, Fillingim RB, Gewandter JS, Katz NP, Kopecky EA, Markman JD, Nomikos G, Porter L, Rappaport BA, Rice ASC, Scavone JM, Scholz J, Simon LS, Smith SM, Tobias J, Tockarshewsky T, Veasley C, Versavel M, Wasan AD, Wen W, Yarnitsky D. Edwards RR, et al. Among authors: chappell as. Pain. 2016 Sep;157(9):1851-1871. doi: 10.1097/j.pain.0000000000000602. Pain. 2016. PMID: 27152687 Free PMC article. Review.

Cite

Share

4

Cite

Share

Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review.

Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS. Barrett AM, et al. Among authors: chappell as. Pain Med. 2007 Sep;8 Suppl 2:S50-62. doi: 10.1111/j.1526-4637.2006.00179.x. Pain Med. 2007. PMID: 17714116 Review.

Cite

Share

5

Cite

Share

Pearls and pitfalls of clinical trial investigation: should I get involved in the drug development process?

Chappell AS. Chappell AS. Semin Neurol. 2001 Dec;21(4):417-24. doi: 10.1055/s-2001-19413. Semin Neurol. 2001. PMID: 11774057 Review.

Cite

Share

6

Cite

Share

Estimation of minimum clinically important difference for pain in fibromyalgia.

Mease PJ, Spaeth M, Clauw DJ, Arnold LM, Bradley LA, Russell IJ, Kajdasz DK, Walker DJ, Chappell AS. Mease PJ, et al. Among authors: chappell as. Arthritis Care Res (Hoboken). 2011 Jun;63(6):821-6. doi: 10.1002/acr.20449. Arthritis Care Res (Hoboken). 2011. PMID: 21312349 Free article. Clinical Trial.

Cite

Share

7

Cite

Share

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups.

Bradley LA, Bennett R, Russell IJ, Wohlreich MM, Chappell AS, Wang F, D'Souza DN, Moldofsky H. Bradley LA, et al. Among authors: chappell as. Arthritis Res Ther. 2010;12(4):R141. doi: 10.1186/ar3081. Epub 2010 Jul 14. Arthritis Res Ther. 2010. PMID: 20630058 Free PMC article.

Cite

Share

8

Cite

Share

Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia.

Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS. Mease PJ, et al. Among authors: chappell as. Semin Arthritis Rheum. 2010 Jun;39(6):454-64. doi: 10.1016/j.semarthrit.2008.11.001. Epub 2009 Jan 18. Semin Arthritis Rheum. 2010. PMID: 19152958 Clinical Trial.

Cite

Share

9

Cite

Share

Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.

Skljarevski V, Desaiah D, Zhang Q, Chappell AS, Detke MJ, Gross JL, Ziegler D. Skljarevski V, et al. Among authors: chappell as. Diabetes Metab Res Rev. 2009 Oct;25(7):623-31. doi: 10.1002/dmrr.1000. Diabetes Metab Res Rev. 2009. PMID: 19637208 Clinical Trial.

Cite

Share

10

Cite

Share

A phase II trial of talampanel in subjects with amyotrophic lateral sclerosis.

Pascuzzi RM, Shefner J, Chappell AS, Bjerke JS, Tamura R, Chaudhry V, Clawson L, Haas L, Rothstein JD. Pascuzzi RM, et al. Among authors: chappell as. Amyotroph Lateral Scler. 2010 May 3;11(3):266-71. doi: 10.3109/17482960903307805. Amyotroph Lateral Scler. 2010. PMID: 19961264 Clinical Trial.

Cite

Share